Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» chronic lymphocytic leukemia
chronic lymphocytic leukemia
MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting
Yahoo/PR Newswire
Sun, 12/7/14 - 10:08 am
MorphoSys
Xencor
MOR208
chronic lymphocytic leukemia
leukemia
Interim Data From Phase 1 Dose Escalation Clinical Trial of TGR-1202, the Once-Daily PI3K Delta Inhibitor, Demonstrates Significant Clinical Activity and Lack of Hepatic Toxicity in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Non-H
Yahoo/Globe NewsWire
Sun, 12/7/14 - 10:04 am
TGR-1202
chronic lymphocytic leukemia
non-Hodgkin's lymphoma
TG Therapeutics
FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications
Marketwatch
Mon, 07/28/14 - 01:28 pm
FDA
Imbruvica
chronic lymphocytic leukemia
FDA approves Gilead Sciences' Zydelig for 3 forms of blood cancer
Yahoo/AP
Wed, 07/23/14 - 04:33 pm
FDA
Zydelig
Gilead Sciences
chronic lymphocytic leukemia
follicular lymphoma
small lymphocytic lymphoma
AbbVie Presents New Results from Studies of Investigational Oncology Compound ABT-199/GDC-0199 at the 2014 American Society of Clinical Oncology Annual Meeting
Yahoo/PR NewsWire
Sat, 05/31/14 - 10:34 am
AbbVie
ABT-199
chronic lymphocytic leukemia
leukemia
non-Hodgkin's lymphoma
3 Breakthrough Drugs Yield 1 Instant Blockbuster
Motley Fool
Sun, 05/25/14 - 10:26 am
Roche
Gazyva
Imbruvica
JNJ
Gilead Sciences
Sovaldi
mantle cell lymphoma
chronic lymphocytic leukemia
leukemia
Biogen
hepatitis
hepatitus C
Pharmacyclics Drug Imbruvica Beats Rivals: Nomura
Investors.com
Thu, 03/20/14 - 05:26 pm
Imbruvica
Pharmacyclics
Gilead Sciences
Biogen Idec
chronic lymphocytic leukemia
J&J, Pharmacyclics drug gets U.S. approval for leukemia
Yahoo/Reuters
Wed, 02/12/14 - 06:46 pm
FDA
JNJ
Pharmacyclics
Imbruvica
chronic lymphocytic leukemia
Pharmacyclics Shares Rise on Positive Leukemia Trial
Bloomberg
Tue, 01/7/14 - 11:49 am
Pharmacyclics
JNJ
Imbruvica
chronic lymphocytic leukemia
New Leukemia Drugs Bring Chemotherapy-Free Treatment Potential
Bloomberg
Mon, 12/9/13 - 08:38 am
Gilead Sciences
Roche
Pharmacyclics
CLL
chronic lymphocytic leukemia
Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia
Yahoo/BusinessWire
Sun, 12/8/13 - 12:03 pm
chronic lymphocytic leukemia
GS-9973
Gilead Sciences
Ditching Big Drugmakers for Biotech Brings Leukemia Boon
Bloomberg
Thu, 12/5/13 - 08:26 am
chronic lymphocytic leukemia
Gilead
Pharmacyclics
CLL
Roche
Gilead’s Idelalisib Significantly Reduces Rate of Disease Progression or Death in Phase 3 Chronic Lymphocytic Leukemia Study
Yahoo
Mon, 11/18/13 - 10:28 am
Gilead
Idelalisib
CLL
chronic lymphocytic leukemia
Roche's Gazyva Approval Marks Success in Oncology and New FDA Designation
Motley Fool
Tue, 11/5/13 - 03:55 pm
Roche
Gazyva
FDA
CLL
chronic lymphocytic leukemia
FDA approves Roche leukemia drug Gazyva
Reuters
Fri, 11/1/13 - 11:48 am
FDA
Roche
Gazyva
chronic lymphocytic leukemia
CLL
GSK/Genmab file Arzerra for first-line CLL
Pharma Times, UK
Mon, 10/21/13 - 09:56 am
Arzerra
GSK
Genmab
CLL
chronic lymphocytic leukemia
Gilead Stops Leukemia Drug Trial Early on Patient Benefit
Bloomberg
Thu, 10/10/13 - 08:13 am
Gilead Sciences
Idelalisib
Rituxan
chronic lymphocytic leukemia
GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(R) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Yahoo/Globe Newswire
Sat, 10/5/13 - 09:31 am
ofatumumab
GSK
Genmab
Arzerra
leukemia
chronic lymphocytic leukemia
Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?
Motley Fool
Wed, 09/18/13 - 10:34 am
chronic lymphocytic leukemia
Sanofi
Campath
GSK
Arzerra
Roche
Rituxan
ibrutinib
Pharmacyclics
obinutuzumab
JNJ
Genmab
Breakthrough status for GSK and Genmab leukemia drug
Pharma Times, UK
Mon, 09/16/13 - 10:14 am
GSK
Genmab
breakthrough therapies
Arzerra
chronic lymphocytic leukemia
FDA
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »